2018
Hypertension Canada’s 2018 Guidelines for the Management of Hypertension in Pregnancy
Butalia S, Audibert F, Côté AM, Firoz T, Logan AG, Magee LA, Mundle W, Rey E, Rabi DM, Daskalopoulou SS, Nerenberg KA, Canada H. Hypertension Canada’s 2018 Guidelines for the Management of Hypertension in Pregnancy. Canadian Journal Of Cardiology 2018, 34: 526-531. PMID: 29731014, DOI: 10.1016/j.cjca.2018.02.021.Peer-Reviewed Original ResearchConceptsManagement of hypertensionAntihypertensive therapySevere hypertensionBlood pressure targetsNewborn adverse outcomesManagement of womenTreatment of hypertensionGynaecologists of CanadaSociety of ObstetriciansAntihypertensive medicationsNonsevere hypertensionPressure targetsNewborn complicationsAdverse outcomesCanadian recommendationsHypertensionPregnancyCanada guidelinesTherapyGuidelinesSpecific evidenceManagementMedicationsComplicationsObstetricians
2014
Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review
Firoz T, Magee L, MacDonell K, Payne B, Gordon R, Vidler M, von Dadelszen P, Group T. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review. BJOG An International Journal Of Obstetrics & Gynaecology 2014, 121: 1210-1218. PMID: 24832366, PMCID: PMC4282072, DOI: 10.1111/1471-0528.12737.Peer-Reviewed Original ResearchConceptsOral antihypertensive agentsSevere hypertensionAntihypertensive agentsRelative riskOral antihypertensive therapySublingual nifedipine capsulesBlood pressure reductionRisk of strokePregnancy/postpartumResource-constrained settingsAntihypertensive therapyExperienced hypotensionOral labetalolOral nifedipineParenteral hydralazineFetal outcomesOral agentsPostpartum hypertensionDiastolic BPSystolic BPDATA COLLECTIONNifedipine capsulesTarget BPCochrane LibraryPostpartum women